Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Saskatchewan

$54,000.00

Investigating enzymatic activity, mechanism, and inhibition

FY 2018-19

Summary
Enzymes are proteins that catalyze chemical reactions, and all living things rely on them for life. They are complex molecules, often performing complex chemistry while providing billion-fold rate acceleration. My research program seeks to improve our understanding of these processes, studying the relationship between structure, function, and catalysis in the context of evolution at the molecular level. I have been training the next generation of academic and industrial scientists and teachers for 14 years in a multidisciplinary environment using state of the art facilities, recently upgraded with a $1.6M grant from Canada Foundation for Innovation.* We can learn about medically beneficial compounds by studying the catalytic pathways by which organisms make naturally-occurring antibiotic or antifungal compounds. This has the advantage of teaching us about the many types of enzymatic chemistry possible, with the downstream application of adapting these pathways to producing these compounds to enhance human health. * My laboratory has established its reputation studying enzymes with unknown or poorly understood function. This has the special challenge of often not knowing what molecules act as substrates for the enzyme. While challenging, this maximizes the element of discovery in my program. We use a family of enzymes related to inositol dehydrogenase as a model system for learning about how enzymes select and activate molecules for reaction, and we have developed a new method of producing inositol labeled with the stable isotope carbon-13 to allow new ways of studying these reactions. * Recently our studies of such enzymes led us to discover a new pathway for biosynthesis of kanosamine, an antibiotic and antifungal compound and precursor to other antibiotics. A set of three enzymes from the bacteria Bacillus subtilis transform a very common precursor, glucose-6-phosphate, into kanosamine. They do so by oxidation, followed by transfer of an amino group from the amino acid glutamate, and finally removal of the phosphate group. Each enzyme belongs to a large family of enzymes with similar function and structure, but each has unique characteristics as well. In particular, the first (oxidation) step results in an unusual product that is difficult to isolate and likely is processed by the next enzyme as soon as it forms. We will study how these enzymes work individually and together in this catalytic process, studying their catalytic attributes, interactions and structures. How proteins work together is one of the frontier areas of inquiry in medicinal chemistry.* Our work also involves the design and synthesis of new inhibitors that target bacterial enzymes. One such enzyme is dihydrodipicolinate synthase, which bacteria require for constructing their cell walls. Inhibiting this enzyme can result in halting bacterial growth. We have recently developed a very potent inhibitor of this enzyme, and we are interested in understanding how it works to hinder catalysis, since it does not bind to the active site of the enzyme (where catalysis takes place), nor does it induce a large change in the shape of the enzyme. We will use techniques such as nuclear magnetic resonance, mass spectrometry, isothermal titration calorimetry, and surface plasmon resonance to study the different effects of inhibitors with similar structures but very different potencies. We are interested in the proposal that enzymes rely on dynamics (movement of the structure) in order to catalyze reactions, and we believe we can probe these dynamics in the presence and absence of these inhibitors. Our understanding of this inhibition will guide us and others in the design of effective new enzyme inhibitors.
Program
Discovery Grants Program - Individual
Location
Saskatchewan, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2014-06585
Name nom
Palmer, David
Department département
Chemistry - Chemistry
Organization id
16
Institution établissement
University of Saskatchewan
Province en
Saskatchewan
Province fr
Saskatchewan
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2014
Award amount
54000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5404
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Enzymes
Research subject fr
Enzymes
Partie
5
Nb partie
7
Application title
Investigating enzymatic activity, mechanism, and inhibition
Keyword
NSERC
Application summary
Enzymes are proteins that catalyze chemical reactions, and all living things rely on them for life. They are complex molecules, often performing complex chemistry while providing billion-fold rate acceleration. My research program seeks to improve our understanding of these processes, studying the relationship between structure, function, and catalysis in the context of evolution at the molecular level. I have been training the next generation of academic and industrial scientists and teachers for 14 years in a multidisciplinary environment using state of the art facilities, recently upgraded with a $1.6M grant from Canada Foundation for Innovation.* We can learn about medically beneficial compounds by studying the catalytic pathways by which organisms make naturally-occurring antibiotic or antifungal compounds. This has the advantage of teaching us about the many types of enzymatic chemistry possible, with the downstream application of adapting these pathways to producing these compounds to enhance human health. * My laboratory has established its reputation studying enzymes with unknown or poorly understood function. This has the special challenge of often not knowing what molecules act as substrates for the enzyme. While challenging, this maximizes the element of discovery in my program. We use a family of enzymes related to inositol dehydrogenase as a model system for learning about how enzymes select and activate molecules for reaction, and we have developed a new method of producing inositol labeled with the stable isotope carbon-13 to allow new ways of studying these reactions. * Recently our studies of such enzymes led us to discover a new pathway for biosynthesis of kanosamine, an antibiotic and antifungal compound and precursor to other antibiotics. A set of three enzymes from the bacteria Bacillus subtilis transform a very common precursor, glucose-6-phosphate, into kanosamine. They do so by oxidation, followed by transfer of an amino group from the amino acid glutamate, and finally removal of the phosphate group. Each enzyme belongs to a large family of enzymes with similar function and structure, but each has unique characteristics as well. In particular, the first (oxidation) step results in an unusual product that is difficult to isolate and likely is processed by the next enzyme as soon as it forms. We will study how these enzymes work individually and together in this catalytic process, studying their catalytic attributes, interactions and structures. How proteins work together is one of the frontier areas of inquiry in medicinal chemistry.* Our work also involves the design and synthesis of new inhibitors that target bacterial enzymes. One such enzyme is dihydrodipicolinate synthase, which bacteria require for constructing their cell walls. Inhibiting this enzyme can result in halting bacterial growth. We have recently developed a very potent inhibitor of this enzyme, and we are interested in understanding how it works to hinder catalysis, since it does not bind to the active site of the enzyme (where catalysis takes place), nor does it induce a large change in the shape of the enzyme. We will use techniques such as nuclear magnetic resonance, mass spectrometry, isothermal titration calorimetry, and surface plasmon resonance to study the different effects of inhibitors with similar structures but very different potencies. We are interested in the proposal that enzymes rely on dynamics (movement of the structure) in order to catalyze reactions, and we believe we can probe these dynamics in the presence and absence of these inhibitors. Our understanding of this inhibition will guide us and others in the design of effective new enzyme inhibitors.
University of Saskatchewan - $54,000 Grant (2018-19) | Canada Spends